KD Logo

Climb Bio Inc [CLYM] Records 200-Day SMA of $5.6500

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Climb Bio Inc shares valued at $2,495 were sold by Pimblett Emily on Dec 19 ’24. At $2.02 per share, Pimblett Emily sold 1,235 shares. The insider’s holdings dropped to 11,329 shares worth approximately $25716.83 following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Pimblett Emily sold 1,191 shares, netting a total of over 9,741 in proceeds. Following the sale of shares at $8.18 each, the insider now holds 7,564 shares.

Before that, Morisset Valerie had sold 69,005 shares from its account. In a trade valued at $554,170, the EVP, R&D AND CSO traded Climb Bio Inc shares for $8.03 each. Upon closing the transaction, the insider’s holdings decreased to 69,005 shares, worth approximately $71089.59.

As published in their initiating research note from Leerink Partners on December 02, 2024, Climb Bio Inc [CLYM] has been an Outperform and the price target has been revised to $10.

Analyzing CLYM Stock Performance

During the last five days, there has been a surge of approximately 12.10%. Over the course of the year, Climb Bio Inc shares have dropped approximately -15.93%. Shares of the company reached a 52-week high of $11.5500 on 05/03/24 and a 52-week low of $1.8600 on 12/23/24. A 50-day SMA is recorded $3.3700, while a 200-day SMA reached $5.6500. Nevertheless, trading volume fell to 0.85 million shares from 0.8 million shares the previous day.

Support And Resistance Levels for Climb Bio Inc (CLYM)

According to the 24-hour chart, there is a support level at 2.0300, which, if violated, would cause prices to drop to 1.8000. In the upper region, resistance lies at 2.4300. The next price resistance is at 2.6000. RSI (Relative Strength Index) is 35.60 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.4200, which suggests the price will decrease in the coming days. Percent R is at 69.63%, indicating low price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular